Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
84.8M
-
Shares change
-
-2.71M
-
Total reported value, excl. options
-
$3.86B
-
Value change
-
-$118M
-
Put/Call ratio
-
0.16
-
Number of buys
-
104
-
Number of sells
-
-113
-
Price
-
$45.45
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2016
268 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q2 2016.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.8M shares
of 99.6M outstanding shares and own 85.11% of the company stock.
Largest 10 shareholders include FMR LLC (12.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.19M shares), VANGUARD GROUP INC (6.08M shares), BB BIOTECH AG (3.12M shares), PERCEPTIVE ADVISORS LLC (2.8M shares), JANUS CAPITAL MANAGEMENT LLC (2.17M shares), BlackRock Institutional Trust Company, N.A. (2.01M shares), BlackRock Fund Advisors (1.94M shares), STATE STREET CORP (1.92M shares), and ORBIMED ADVISORS LLC (1.82M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.